UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An Experiment in Linguistic Synthesis with a Fuzzy Logic Controller

International journal of human-computer studies, 1999-08, Vol.51 (2), p.135-147

1999

Volltextzugriff (PDF)

EP11.01-10 Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer: Does Histology Matter?

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S613-S614

2023

Volltextzugriff (PDF)

698P Interim results from a phase I/II study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T cell engager in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine neoplasms (NEN)

Annals of oncology, 2023-10, Vol.34, p.S486-S486

2023

Volltextzugriff (PDF)

MA12.05 Is there a Role for Surgery in Stage I Small Cell Lung Cancer? A National VA Database Analysis

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S178-S178

2021

Volltextzugriff (PDF)

1172P High activity of poziotinib in G778_P780dup HER2 exon 20 insertion mutations in non-small cell lung cancer (NSCLC)

Annals of oncology, 2022-09, Vol.33, p.S1084-S1085

2022

Volltextzugriff (PDF)

526P Pharmacodynamic evidence for WEE1 target engagement in surrogate and tumor tissues from a phase I study of the WEE1 inhibitor ZN-c3

Annals of oncology, 2021-09, Vol.32, p.S593-S593

2021

Volltextzugriff (PDF)

MA06.05 Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S64

2022

Volltextzugriff (PDF)

1066P Tumor microenvironment (TME) of HRAS mutated non-small cell lung cancer (NSCLC)

Annals of oncology, 2022-09, Vol.33, p.S1041

2022

Volltextzugriff (PDF)

1723P CLEC3B mRNA expression levels are linked to distinct genetic backgrounds, transcriptomic signatures and survival in NSCLC

Annals of oncology, 2022-09, Vol.33, p.S1325

2022

Volltextzugriff (PDF)

P1.01-74 A Retrospective Study Evaluating Clinical Predictors of Duration of Response to Immune Checkpoint Inhibitors in Advanced NSCLC

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S388-S389

2019

Volltextzugriff (PDF)

P1.16-27 Risk Factors Associated with a Second Primary Lung Cancer (SPLC) in Patients (Pts) with an Initial Primary Lung Cancer (IPLC)

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S597-S598

2019

Volltextzugriff (PDF)

EP1.01-67 Molecular Profiling of K-Ras and Its Subtypes in NSCLC Patients with Liver Metastasis

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S938-S938

2019

Volltextzugriff (PDF)

P2.01-29 The Correlation Between K-Ras Mutant Subsets with TP53 Mutation and PD-L1 in Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S650-S650

2019

Volltextzugriff (PDF)

P-48 Phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: Cohort of subjects with checkpoint inhibitor-naïve advanced pancreatic cancer

Annals of oncology, 2022-06, Vol.33, p.S263-S264

2022

Volltextzugriff (PDF)

P-54 Phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: Cohort of subjects with checkpoint inhibitor-naïve advanced MSS-colorectal cancer

Annals of oncology, 2022-06, Vol.33, p.S266

2022

Volltextzugriff (PDF)

P01.06 CX-2029, a Probody Drug Conjugate Targeting CD71 in Patients With Selected Tumor Types: PROCLAIM-CX-2029 Dose Expansion Phase

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S238-S238

2021

Volltextzugriff (PDF)

P2.01-100 Spectrum of EGFR Exon 20 Insertion Mutations and Co-Occurring Genetic Alterations in Patients with Non-Small-Cell Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S680-S680

2019

Volltextzugriff (PDF)

P76.43 Co-occurring genomic alterations and treatment outcomes in patients with EGFR exon 20 insertion positive NSCLC

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S605-S606

2021

Volltextzugriff (PDF)

P1.01-84 Interaction of Lorlatinib with CYP2B6, CYP2C9, UGT, and P-gp Probe Drugs in Patients with Advanced Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S392-S393

2019

Volltextzugriff (PDF)

Degrees of uncertainty

Nature, 1992-10, Vol.359 (6398), p.788-788

Mamdani, E. H

1992

Volltextzugriff (PDF)

Molecular Profiling of K-Ras and Its Subtypes in NSCLC Patients with Liver Metastasis: EP1.01-67

Journal of thoracic oncology, 2019-10, Vol.14 (10 Suppl), p.S938-S938

2019

Volltextzugriff (PDF)

Diagnosis of autism: adequate funding is needed for assessment services

BMJ, 2004-01, Vol.328 (7433), p.226-226

International edition, 2004

Volltextzugriff (PDF)

Application of Fuzzy Logic to Approximate Reasoning Using Linguistic Synthesis

IEEE transactions on computers, 1977-12, Vol.C-26 (12), p.1182-1191

Mamdani

1977

Volltextzugriff (PDF)

A linguistic self-organizing process controller

Automatica (Oxford), 1979, Vol.15 (1), p.15-30

1979

Volltextzugriff (PDF)

Prescriptive method for deriving control policy in a fuzzy-logic controller

Electronics letters, 1975-12, Vol.11 (25-26), p.625

1975

Volltextzugriff (PDF)

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(138)

Publikationsform

Sprache

Englisch
(182)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An Experiment in Linguistic Synthesis with a Fuzzy Logic Controller

EP11.01-10 Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer: Does Histology Matter?

698P Interim results from a phase I/II study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T cell engager in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine neoplasms (NEN)

MA12.05 Is there a Role for Surgery in Stage I Small Cell Lung Cancer? A National VA Database Analysis

1172P High activity of poziotinib in G778_P780dup HER2 exon 20 insertion mutations in non-small cell lung cancer (NSCLC)

526P Pharmacodynamic evidence for WEE1 target engagement in surrogate and tumor tissues from a phase I study of the WEE1 inhibitor ZN-c3

MA06.05 Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC

1066P Tumor microenvironment (TME) of HRAS mutated non-small cell lung cancer (NSCLC)

1723P CLEC3B mRNA expression levels are linked to distinct genetic backgrounds, transcriptomic signatures and survival in NSCLC

P1.01-74 A Retrospective Study Evaluating Clinical Predictors of Duration of Response to Immune Checkpoint Inhibitors in Advanced NSCLC

P1.16-27 Risk Factors Associated with a Second Primary Lung Cancer (SPLC) in Patients (Pts) with an Initial Primary Lung Cancer (IPLC)

EP1.01-67 Molecular Profiling of K-Ras and Its Subtypes in NSCLC Patients with Liver Metastasis

P2.01-29 The Correlation Between K-Ras Mutant Subsets with TP53 Mutation and PD-L1 in Non-Small Cell Lung Cancer (NSCLC)

P-48 Phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: Cohort of subjects with checkpoint inhibitor-naïve advanced pancreatic cancer

P-54 Phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: Cohort of subjects with checkpoint inhibitor-naïve advanced MSS-colorectal cancer

P01.06 CX-2029, a Probody Drug Conjugate Targeting CD71 in Patients With Selected Tumor Types: PROCLAIM-CX-2029 Dose Expansion Phase

P2.01-100 Spectrum of EGFR Exon 20 Insertion Mutations and Co-Occurring Genetic Alterations in Patients with Non-Small-Cell Lung Cancer

P76.43 Co-occurring genomic alterations and treatment outcomes in patients with EGFR exon 20 insertion positive NSCLC

P1.01-84 Interaction of Lorlatinib with CYP2B6, CYP2C9, UGT, and P-gp Probe Drugs in Patients with Advanced Non-Small Cell Lung Cancer

Degrees of uncertainty

Molecular Profiling of K-Ras and Its Subtypes in NSCLC Patients with Liver Metastasis: EP1.01-67

Diagnosis of autism: adequate funding is needed for assessment services

Application of Fuzzy Logic to Approximate Reasoning Using Linguistic Synthesis

A linguistic self-organizing process controller

Prescriptive method for deriving control policy in a fuzzy-logic controller

Suchergebnisse filtern